High-Field Magnetic Resonance Imaging for Epilepsy

Neuroimaging Clinics of North America

Volumn 22, Issue 2, 2012, Pages 173-189

  Urbach, Horst ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Drug resistant epilepsy; Epilepsy; Epilepsy surgery; High field MR imaging; MR imaging

Indexed keywords

BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ATROPHY; BRAIN CORTEX LESION; BRAIN DAMAGE; BRAIN MALFORMATION; BRAIN TUMOR; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; GRAY MATTER; HIGH MAGNETIC RESONANCE IMAGING; HIPPOCAMPAL SCLEROSIS; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; LARMOR FREQUENCY; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY RADIATION; RADIOLOGICAL PARAMETERS; RELAXATION TIME; REVIEW; SIGNAL NOISE RATIO; TRAUMATIC BRAIN INJURY; TUMOR CLASSIFICATION;

BRAIN; EPILEPSY; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING;

EID: 84860355158     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2012.02.008     Document Type: Review

References (51)

1. Rosenow F., Lüders H. Presurgical evaluation of epilepsy. Brain 2001, 124(Pt 9):1683-1700.
2. Wagner J., Weber B., Urbach H., et al. Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain 2011, 134(Pt 10):2844-2854.
3. Wagner J., Wellmer J., Urbach H., et al. Focal cortical dysplasia type IIb: completeness of cortical, not subcortical resection is necessary for seizure freedom. Epilepsia 2011, 52(8):1418-1424.
4. Bien C.G., Szinai M., Wagner J., et al. Characteristics and surgical outcome of patients with refractory MRI-negative epilepsies. Arch Neurol 2009, 66(12):1491-1499.
5. Bien C.G., Raabe A.L., Schramm J., et al. Long-term developments in presurgical evaluation and surgical treatment of epilepsy at one tertiary center: Part II: surgical outcome. Epilepsia 2010, 51(Suppl 4):6.
6. Berg A.T., Berkovic S.F., Brodie M., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
7. Phal P.M., Usmanov A., Nesbit G.M., et al. Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy. AJR Am J Roentgenol 2008, 191(3):890-895.
8. Knake S., Triantafyllou C., Wald L.L., et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology 2005, 65(7):1026-1031.
9. Willinek W.A., Kuhl C.K. 3.0 T neuroimaging: technical considerations and clinical applications. Neuroimaging Clin N Am 2006, 16(2):217-218.
10. Wansapura J.P., Holland S.K., Dunn R.S., et al. NMR relaxation times in the human brain at 3.0 T. J Magn Reson Imaging 1999, 9(4):531-538.
11. Lin C, Bernstein MA, Huston J, et al. In-vivo and in-vitro measurements of T1 relaxation at 3.0T. In: Proceedings of the 9th Meeting ISMRM. Glasgow, 2001. p. 1685.
12. Elster A.D., Mirza W. MR imaging in chronic partial epilepsy: role of contrast enhancement. AJNR Am J Neuroradiol 1991, 12(1):165-170.
13. Huppertz H.J., Wellmer J., Staack A.M., et al. Voxel-based 3-D MRI analysis helps to detect subtle forms of subcortical band heterotopia. Epilepsia 2008, 49(5):772-785.
14. Hattingen E., Hattingen J., Clusmann H., et al. Planar brain surface reformations for localization of cortical brain lesions. Zentralbl Neurochir 2004, 65(2):75-80.
15. Nelles M., Bien C.G., Kurthen M., et al. Transient splenium lesions in presurgical epilepsy patients: incidence and pathogenesis. Neuroradiology 2006, 48(7):443-448.
16. Pruessmann K.P., Weiger M., Scheidegger M.B., et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999, 42(5):952-962.
17. Bammer R., Keeling S.L., Augustin M., et al. Improved diffusion-weighted single-shot-echo-planar imaging in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001, 46(3):548-554.
18. Willinek W.A., Schild H.H. Clinical advantages of 3.0T MRI over 1.5T. Eur J Radiol 2008, 65(1):2-14.
19. Hoult D.I., Phil D. Sensitivity and power deposition in a high-field imaging experiment. J Magn Reson Imaging 2000, 12(1):46-67.
20. Urbach H., Hattingen J., von Oertzen J., et al. MRI in the presurgical evaluation of patients with drug-resistant epilepsy. AJNR Am J Neuroradiol 2004, 25(6):919-926.
21. Wiebe S., Blume W.T., Girvin J.P., et al. A randomized, controlled trial of surgery for temporal lobe epilepsy. N Engl J Med 2001, 38:154-163.
22. Hirai T., Korogi Y., Yoshizumi Y., et al. Limbic lobe of the human brain: evaluation with turbo fluid-attenuated inversion recovery MR imaging. Radiology 2000, 215(2):470-475.
23. Blümcke I., Pauli E., Clusmann H., et al. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol 2007, 113(3):235-244.
24. Thom M., Liagkouras I., Elliot K.J., et al. Reliability of patterns of hippocampal sclerosis as predictors of postsurgical outcome. Epilepsia 2010, 51(9):1801-1808.
25. Luyken C., Blümcke I., Fimmers R., et al. The spectrum of long-term epilepsy associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003, 44(6):822-830.
26. Louis D.N., Ohgaki H., Wiestler O.D., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114(2):97-109.
27. Daumas-Duport C., Pietsch T., Lantos P.L. Dysembryoplastic neuroepithelial tumour. Pathology and genetic of tumours of the nervous system 2000, 103-106. IARC press, Lyon (France). P. Kleihues, K. Cavenee (Eds.).
28. Campos A.R., Clusmann H., von Lehe M., et al. Simple and complex dysembryoplastic neuroepithelial tumors (DNT): clinical profile, MRI and histopathology. Neuroradiology 2009, 51(7):433-443.
29. Lellouch-Tubiana A., Boddaert N., Bourgeois M., et al. Angiocentric neuroepithelial tumor (ANET): a new Epilepsy-related clinicopathological entity with distinctive MRI. Brain Pathol 2005, 15(4):281-286.
30. Wang M., Tihan T., Rojiani A.M., et al. Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma. J Neuropathol Exp Neurol 2005, 64(10):875-881.
31. Palmini A., Najm I., Avanzini G., et al. Terminology and classification of the cortical dysplasias. Neurology 2004, 62(6 Suppl 3):S2-S8.
32. Barkovich A.J., Kuzniecky R.I., Jackson G.D., et al. A developmental and genetic classification for malformations of cortical development. Neurology 2005, 65(12):1873-1887.
33. Blümcke I., Thom M., Aronica E., et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011, 52(1):158-174.
34. Dobyns W.B. The clinical patterns and molecular genetics of lissencephaly and subcortical band heterotopia. Epilepsia 2010, 51(Suppl 1):5-9.
35. Leventer R.J., Jansen A., Pilz D.T., et al. Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain 2010, 133(Pt 5):1415-1427.
36. Taylor D.C., Falconer M.A., Bruton C.J., et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971, 34(4):369-387.
37. Barkovich A.J., Kuzniecky R.I., Bollen A.W., et al. Focal transmantle dysplasia: a specific malformation of cortical development. Neurology 1997, 49(4):1148-1152.
38. Urbach H., Scheffler B., Heinrichsmeier T., et al. Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 2002, 43(1):33-40.
39. Besson P., Andermann F., Dubeau F., et al. Small focal cortical dysplasia lesions are located at the bottom of a deep sulcus. Brain 2008, 131(Pt 12):3246-3255.
40. Chamberlain W.A., Cohen M.L., Gyure K.A., et al. Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Epilepsia 2009, 50(12):2593-2598.
41. Hildebrandt M., Pieper T., Winkler P., et al. Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol 2005, 110(1):1-11.
42. Krsek P., Maton B., Korman B., et al. Different features of histopathological subtypes of pediatric focal cortical dysplasia. Ann Neurol 2008, 63(6):758-769.
43. Fauser S., Huppertz H.J., Bast T., et al. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 2006, 129(Pt 7):1907-1916.
44. Hamilton B.E., Nesbit G.M. MR imaging identification of oligodendroglial hyperplasia. AJNR Am J Neuroradiol 2009, 30(7):1412-1413.
45. Lerner J.T., Salaman N., Hauptman J.S., et al. Assessment of surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009, 50(6):1310-1335.
46. Krsek P., Maton B., Jayakar P., et al. Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology 2009, 72(3):217-223.
47. Hayashi N., Tsutsumi Y., Barkovich A.J. Polymicrogyria without porencephaly/schizencephaly. MRI analysis of the spectrum and the prevalence of macroscopic findings in the clinical population. Neuroradiology 2002, 44(8):647-655.
48. Moran N.F., Fish D.R., Kitchen N., et al. Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 1999, 66(5):561-568.
49. Zhao J., Wang S., Li J., et al. Clinical characteristics and surgical results of patients with cerebral arteriovenous malformations. Surg Neurol 2005, 63(2):156-161.
50. Willinek W.A., Born M., Simon B., et al. 3.0 T time of flight MR angiography: comparison with 1.5 T-initial experience. Radiology 2003, 229(3):913-920.
51. Hadizadeh D., Gieseke J., von Falkenhausen M., et al. Subsecond temporal resolution 4D-MR angiography: Spetzler-Martin classification of cerebral arteriovenous malformations as compared to DSA. Radiology 2008, 246(1):205-213.